BB Biotech AG's Shareholders Approve Dividend and Elect New Chairman

On March 21, 2024, BB Biotech AG announced that its shareholders approved all proposals presented by the Board of Directors during its Annual General Meeting. Notably, the shareholders agreed to a dividend payout of CHF 2.00 per share, with the payment set for March 27, 2024. The company has scheduled the record date for March 26, 2024, and the ex-dividend date for March 25, 2024.

In a significant board reshuffle, Dr. Thomas von Planta was elected as the new Chairman of the Board, taking over from Dr. Erich Hunziker, who stepped down and did not seek re-election. Hunziker's leadership contributions over 13 years were acknowledged with gratitude. Additionally, Camilla Soenderby joins the board as a new member. Current board members Dr. Clive Meanwell, Laura Hamill, Dr. Pearl Huang, and Prof. Dr. Mads Krogsgaard Thomsen were re-elected for another year.